You just read:

OphthaliX to Retrospectively Analyze Phase III Dry Eye Syndrome Study Data Based on A3 Adenosine Receptor Biomarker

News provided by

Can-Fite BioPharma Ltd.

Dec 31, 2013, 07:00 ET